REQUEST A DEMO
Total
USD $0.00
Search more companies

Hpgc Renmintongtai Pharmaceutical Corporation (China)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Hpgc Renmintongtai Pharmaceutical Corporation Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

SANJING PHARMACEUTICAL CO., LTD. is one of the most high-quality enterprises under the Harbin Pharmaceutical Group. It is a national pharmaceutical company integrating research, manufacturing, sales and trade in one. In 2004 it got listed using the Swan Shares. In the second half year of 2005, it was stripped the cement assets which was at loss. The company's main varieties are in the OTC market. As China's OTC market started late, it is currently in rapid development period. The market shares of three pillars of gluconate, zinc gluconate, Shuanghuanglian oral rank No.1 and their positions as famous brands have been established. The Company also have outstand performance in marketing, channel, quality, cost management and reserves, and other aspects.

Headquarters
No. 418, Harbin Pharmaceutical Road, Daoli District, Harbin City, Heilongjiang Province
Harbin; Heilongjiang; Postal Code: 150071

Contact Details: Purchase the Hpgc Renmintongtai Pharmaceutical Corporation report to view the information.

Website: http://www.hyrmtt.com.cn

Basic Information
Total Employees:
Purchase the Hpgc Renmintongtai Pharmaceutical Corporation report to view the information.
Outstanding Shares:
Purchase the Hpgc Renmintongtai Pharmaceutical Corporation report to view the information.
Registered Capital:
Purchase the Hpgc Renmintongtai Pharmaceutical Corporation report to view the information.
Financial Auditors:
Purchase the Hpgc Renmintongtai Pharmaceutical Corporation report to view the information.
Incorporation Date:
February 05, 1994
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
74.82%
Purchase this report to view the information.
0.43%
Purchase this report to view the information.
0.25%
Purchase this report to view the information.
0.22%
Purchase this report to view the information.
0.22%
Subsidiaries
Harbin Pharmaceutical Group Harbin Pharmaceutical Commercial Co., Ltd.
100%
Harbin Pharmaceutical Group Harbin Pharmaceutical Xinjian Pharmaceutical Co., Ltd.
100%
Harbin Pharmaceutical Group Heihe Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hpgc Renmintongtai Pharmaceutical Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-1.88%
Total operating revenue
-1.78%
Operating profit (EBIT)
-13.8%
Net Profit (Loss) for the Period
-14.39%
Total assets
-3.35%
Total equity
6.28%
Operating Profit Margin (ROS)
-0.48%
Net Profit Margin
-0.4%
Return on Equity (ROE)
-1.73%
Debt to Equity Ratio
-8.37%
Quick Ratio
0.05%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?